EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Levosimendan Pretreatment Attenuates Mesenteric Artery Ischemia/Reperfusion Injury and Multi-Organ Damage in Rats

Zoran Matković, Milica Gajić Bojić iD, Uglješa Maličević iD, Aleksandra Krivokuća, Nebojša Mandić-Kovačević iD, Snežana Uletilović iD, Ljiljana Amidžić iD, Sanja Jovičić iD, Maja Barudžija iD, Miloš P Stojiljković iD, Radoslav Gajanin, Sergej Bolevich und 1 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26189131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Zoran Matković und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, General Hospital "Sveti Apostol Luka", 74000 Doboj, Bosnia and Herzegovina. Hauptthemen laut MEDLINE: Simendan, Reperfusion Injury, Mesenteric Ischemia. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute mesenteric ischemia (AMI) is a life-threatening condition characterised by oxidative stress, inflammation, apoptosis, and necrosis of intestinal epithelial cells. Different drugs with vasoactive, antioxidant, and anti-inflammatory properties have been used to treat AMI. Levosimendan is a drug with proven anti-ischemic effects used in the management of acute congestive heart failure. This study evaluated the protective effects of levosimendan pretreatment on intestinal, as well as lung, heart, and kidney tissue in a rat model of mesenteric artery ischemia/reperfusion (I/R) injury. Male Wistar rats (N = 24) were divided into four groups: control, I/R, levosimendan (LS) 1 mg/kg i.p, and LS + I/R (1 mg/kg i.p. 30 min before injury). I/R by itself caused elevation of oxidative markers (thyobarbituric acid reactive species (TBARS), hydrogen peroxide (H2O2), super oxide anjon radical (O2−), and nitrogen dioxide (NO2−)), induced inflammation (macrophage infiltration and Interleukin-6 (IL-6) production), and apoptosis (nuclear factor kappa light-chain enhancer of activated B cells (NF-κB), cleaved caspase-3 (CC3), and terminal deoxy-nucleotidyl transferase (TdT)-mediated dUTP nick end labelling (TUNEL)). Levosimendan pretreatment significantly reduced oxidative stress markers and enhanced antioxidant defences (catalase (CAT), reduced glutathione (GSH), and superoxide dismutase (SOD)). Histological analysis revealed reduced mucosal damage and preserved goblet cells in intestinal tissue. Similar protective effects of levosimendan were observed in other organs such as lung, heart, and kidney. Immunohistochemistry showed reduced epithelial apoptosis and upregulation of antioxidant and anti-inflammatory proteins. These findings highlight levosimendan’s ability to protect mesenteric I/R tissue injury and multi-organ damage by suppressing oxidative stress, inflammation, and apoptosis, emphasising its therapeutic potential in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SimendanReperfusion InjuryMesenteric IschemiaAnimalsMaleRatsRats, WistarOxidative StressApoptosisAntioxidantsMesenteric ArteriesDisease Models, Animal

Stichwörter der Autor:innen

apoptosisinflammationischemia/reperfusionlevosimendanmesenteric arteryoxidative stress

Substanzen

SimendanAntioxidants

Autor:innen und Institutionen

  • Department of Surgery, General Hospital "Sveti Apostol Luka", 74000 Doboj, Bosnia and Herzegovina.
  • Centre for Biomedical Research, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina.
  • Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina.
  • Department of Pathophysiology, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina.
  • Department of Pharmacy, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina.
  • Department of Medical Biochemistry and Chemistry, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina.

ORCID-Profile: Milica Gajić Bojić, Uglješa Maličević, Nebojša Mandić-Kovačević, Snežana Uletilović, Ljiljana Amidžić, Sanja Jovičić, Maja Barudžija, Miloš P Stojiljković, Ranko Škrbić

Zitieren

APA

Matković, Z., Gajić Bojić, M., Maličević, U., Krivokuća, A., Mandić-Kovačević, N., Uletilović, S., Amidžić, L., Jovičić, S., Barudžija, M., Stojiljković, M. P., Gajanin, R., Bolevich, S., & Škrbić, R. (2025). Levosimendan Pretreatment Attenuates Mesenteric Artery Ischemia/Reperfusion Injury and Multi-Organ Damage in Rats. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26189131

Vancouver

Matković Z, Gajić Bojić M, Maličević U, Krivokuća A, Mandić-Kovačević N, Uletilović S, et al. Levosimendan Pretreatment Attenuates Mesenteric Artery Ischemia/Reperfusion Injury and Multi-Organ Damage in Rats. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26189131

BibTeX
@article{Matkovi2025,
  author = {Matković, Zoran and Gajić Bojić, Milica and Maličević, Uglješa and Krivokuća, Aleksandra and Mandić-Kovačević, Nebojša and Uletilović, Snežana and Amidžić, Ljiljana and Jovičić, Sanja and Barudžija, Maja and Stojiljković, Miloš P and Gajanin, Radoslav and Bolevich, Sergej and Škrbić, Ranko},
  title = {Levosimendan Pretreatment Attenuates Mesenteric Artery Ischemia/Reperfusion Injury and Multi-Organ Damage in Rats},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26189131}
}
Kostenlos starten →